DIGESTION AIDS MARKET ANALYSIS

Market Challenges And Opportunities

Global Digestion Aids Market: Drivers

Digestion aids market revenue is expected to witness significant growth, owing to increasing number of new product launches for digestive health in children. For instance, in July 2017, Alcresta Therapeutics received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for the use of RELiZORB in children. RELiZORB is used for Pancreatic and Gastric disorders in both children and adults.

Rising geriatric population and growing awareness regarding gastrointestinal health are also two important factors driving the digestion aids market size. In elderly population functionality of digestive system decreases and muscles in the digestive tract become stiff, weak, and less efficient for food digestion. For instance, according to a study published in BMC Gastroenterology Journal, around 11% of the population suffer from a chronic digestive disease in U.S. with a prevalence rate as high as 35% for those 65 years and above.

Global Digestion Aids Market Restraints

The major restraining factor for digestion aids market growth is the side effects shown by the probiotics and prebiotics. Although there are many benefits, but excess consumption of probiotics can lead to unpleasant digestive symptoms. Amines in probiotic foods may trigger headaches, while some ingredients can cause adverse reactions. According to a study published in National Center for Biotechnology Information (NCBI) in 2012, certain probiotic compounds may contain hidden allergens of food and may not be safe for subjects with allergy to cow's milk or hen's egg.